Gram‐negative toe web intertrigo associated with eczematous dermatoses improved with dupilumab: A case series

Key Points

• The study aims to assess the effects of dupilumab on gram-negative toe web intertrigo associated with eczematous dermatoses.
• Observed patients with intertrigo and eczematous dermatoses
• Administered dupilumab treatment
• Conducted follow-up assessments
• Improvements were noted in the severity of intertrigo
• Patients reported reduced symptoms
• Dupilumab showed effectiveness in managing symptoms